Basma Adeem Medical company (TADAWUL:9626)

TADAWUL:9626 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	37.29	33.92	26.52	21.92
Revenue Growth (YoY)	70.12%	27.88%	20.99%	-
Cost of Revenue	25.72	22.98	18.19	15.02
Gross Profit	11.58	10.94	8.33	6.9
Selling, General & Admin	3.63	3.14	2.48	2.57
Operating Expenses	3.91	3.41	2.74	2.69
Operating Income	7.67	7.52	5.59	4.21
Interest Expense	-0.56	-0.34	-0.36	-0.29
Interest & Investment Income	0.1	0.1	-	-
Other Non Operating Income (Expenses)	-0.24	-0.5	-0.3	-
EBT Excluding Unusual Items	6.97	6.78	4.93	3.92
Other Unusual Items	-0	-0	0.13	-
Pretax Income	6.96	6.78	5.06	3.92
Income Tax Expense	0.49	0.48	0.19	0.14
Net Income	6.47	6.3	4.87	3.78
Net Income to Common	6.47	6.3	4.87	3.78
Net Income Growth	71.11%	29.40%	28.71%	-
Shares Outstanding (Basic)	17	12	10	-
Shares Outstanding (Diluted)	17	12	10	-
Shares Change (YoY)	-	21.59%	-	-
EPS (Basic)	0.38	0.55	0.51	-
EPS (Diluted)	0.38	0.55	0.51	-
EPS Growth	-	6.42%	-	-
Free Cash Flow	3.82	6.66	4.07	5.24
Free Cash Flow Per Share	0.23	0.58	0.43	-
Gross Margin	31.05%	32.25%	31.41%	31.46%
Operating Margin	20.57%	22.18%	21.07%	19.20%
Profit Margin	17.36%	18.58%	18.36%	17.26%
Free Cash Flow Margin	10.24%	19.64%	15.34%	23.90%
EBITDA	8.33	8.15	6.2	4.54
EBITDA Margin	22.33%	24.02%	23.36%	20.71%
D&A For EBITDA	0.66	0.62	0.61	0.33
EBIT	7.67	7.52	5.59	4.21
EBIT Margin	20.57%	22.18%	21.07%	19.20%
Effective Tax Rate	7.04%	7.11%	3.69%	3.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.